Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
CRVO
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +8.7%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
cervomed
neflamapimod
dementia
lewy
clinical
bodies
conference
trial
phase
data
results
treatments
participate
announced
potential
patients
emerging
growth
2025
stage
CRVO
CervoMed Inc. Common Stock